Baynes Roy D. bought TVTX

April 14, 2026 · Form 4 insider transaction

Baynes Roy D. bought 9,000 shares of Travere Therapeutics, Inc. at $15.43 per share, a transaction worth $138.9K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.